Search research articles
Contact Us
Filters
Showing results (211-220 of 574) with videos related to
Page
of 58
Sort By:
Neuro-Oncology Practice
|
January 28, 2022
Factors associated with cognitive impairment and cognitive concerns in patients with metastatic non-small cell lung cancer
Annemarie C Eggen, Nadine M Richard, Ingeborg Bosma, et al.
Journal of Pain and Symptom Management
|
March 8, 2020
Death Anxiety in Patients With Metastatic Non-Small Cell Lung Cancer With and Without Brain Metastases
Annemarie C Eggen, Anna K L Reyners, Gerald Shen, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 27, 2025
Managing lorlatinib together: An overview and practical guide for patients by ALK-positive NSCLC patients and medical experts
Nancee Pronsati, Geoffrey Liu, Todd M Bauer, et al.
Pharmacoepidemiology and Drug Safety
|
March 14, 2021
Pharmacoepidemiology: A time for a new multidisciplinary approach to precision medicine
Amalia M Issa, Bruce Carleton, Tobias Gerhard, et al.
Clinical Lung Cancer
|
March 2, 2016
Cetuximab Inhibits T790M-Mediated Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in a Lung Adenocarcinoma Patient-Derived Xenograft Mouse Model
Petra Martin, Erin Stewart, Nhu-An Pham, et al.
JTO Clinical and Research Reports
|
February 3, 2022
Effects of Ethnicity on Outcomes of Patients With <i>EGFR</i> Mutation-Positive NSCLC Treated With EGFR Tyrosine Kinase Inhibitors and Surgical Resection
Mike R Sung, Pascale Tomasini, Lisa W Le, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
August 18, 2017
Health-related quality of life associated with regorafenib treatment in refractory advanced gastric adenocarcinoma
Andrew J Martin, Emma Gibbs, Katrin Sjoquist, et al.
Current Oncology (Toronto, Ont.)
|
February 26, 2026
Early Experience with Tarlatamab (T-Cell Engagers) for Extensive-Stage Small Cell Lung Cancer (ES-SCLC) in Canada: Lessons Learned and Implementation Strategies
Parneet K Cheema, Kirstin A Perdrizet, Randeep S Sangha, et al.
Lung Cancer (Amsterdam, Netherlands)
|
September 18, 2025
Canadian Perspectives Revisited: Consensus on the management of ALK-rearranged NSCLC
Barbara Melosky, Quincy S C Chu, Rosalyn A Juergens, et al.
Clinical Lung Cancer
|
May 28, 2018
Correlation of Neutrophil to Lymphocyte Ratio and Absolute Neutrophil Count With Outcomes With PD-1 Axis Inhibitors in Patients With Advanced Non-Small-Cell Lung Cancer
Alona Zer, Mike R Sung, Preet Walia, et al.
Page
of 58
Search research articles
Search
Showing results (211-220 of 574) with videos related to
Sort By:
Page
of 58
Neuro-Oncology Practice
|
January 28, 2022
Factors associated with cognitive impairment and cognitive concerns in patients with metastatic non-small cell lung cancer
Annemarie C Eggen, Nadine M Richard, Ingeborg Bosma, et al.
Journal of Pain and Symptom Management
|
March 8, 2020
Death Anxiety in Patients With Metastatic Non-Small Cell Lung Cancer With and Without Brain Metastases
Annemarie C Eggen, Anna K L Reyners, Gerald Shen, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 27, 2025
Managing lorlatinib together: An overview and practical guide for patients by ALK-positive NSCLC patients and medical experts
Nancee Pronsati, Geoffrey Liu, Todd M Bauer, et al.
Pharmacoepidemiology and Drug Safety
|
March 14, 2021
Pharmacoepidemiology: A time for a new multidisciplinary approach to precision medicine
Amalia M Issa, Bruce Carleton, Tobias Gerhard, et al.
Clinical Lung Cancer
|
March 2, 2016
Cetuximab Inhibits T790M-Mediated Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in a Lung Adenocarcinoma Patient-Derived Xenograft Mouse Model
Petra Martin, Erin Stewart, Nhu-An Pham, et al.
JTO Clinical and Research Reports
|
February 3, 2022
Effects of Ethnicity on Outcomes of Patients With <i>EGFR</i> Mutation-Positive NSCLC Treated With EGFR Tyrosine Kinase Inhibitors and Surgical Resection
Mike R Sung, Pascale Tomasini, Lisa W Le, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
August 18, 2017
Health-related quality of life associated with regorafenib treatment in refractory advanced gastric adenocarcinoma
Andrew J Martin, Emma Gibbs, Katrin Sjoquist, et al.
Current Oncology (Toronto, Ont.)
|
February 26, 2026
Early Experience with Tarlatamab (T-Cell Engagers) for Extensive-Stage Small Cell Lung Cancer (ES-SCLC) in Canada: Lessons Learned and Implementation Strategies
Parneet K Cheema, Kirstin A Perdrizet, Randeep S Sangha, et al.
Lung Cancer (Amsterdam, Netherlands)
|
September 18, 2025
Canadian Perspectives Revisited: Consensus on the management of ALK-rearranged NSCLC
Barbara Melosky, Quincy S C Chu, Rosalyn A Juergens, et al.
Clinical Lung Cancer
|
May 28, 2018
Correlation of Neutrophil to Lymphocyte Ratio and Absolute Neutrophil Count With Outcomes With PD-1 Axis Inhibitors in Patients With Advanced Non-Small-Cell Lung Cancer
Alona Zer, Mike R Sung, Preet Walia, et al.
Page
of 58